European startups raised $24 billion in the second quarter, the strongest venture funding quarter the region has posted in four years. The total marks a roughly 33% increase from the previous quarter and a 67% jump compared with the $14.4 billion raised in Q2 2025, according to Crunchbase data.
U.K. Startups Capture a Third of All European Funding
The United Kingdom widened its venture funding lead last quarter, raising $10.4 billion. That figure came within $500 million of the U.K.’s all-time quarterly high set in 2021. Germany followed with $3.2 billion, and France placed third with $2.4 billion. Sweden rounded out the top four with $2 billion.
The U.K.’s strong performance reflects a concentration of large deals in AI-powered drug discovery and other deep technology areas. The country now accounts for more than 40% of all venture capital flowing into Europe this quarter.
Mega-Rounds Drive Growth Across AI and Deep Tech
Four companies each raised $1 billion or more in Q2, together representing 25% of all European startup investment. Three of those four are directly tied to artificial intelligence or advanced technology. The billion-dollar-plus recipients include:
Beyond those outliers, 42 companies raised rounds of $100 million or more, accounting for 65% of all funding. Notable sectors attracting that capital include biotech, quantum computing, financial services, AI labs, aerospace, semiconductors, robotics and energy. The dominance of large rounds shows that investors are backing proven technologies with clear market potential rather than spreading capital across early-stage bets.
Why This Matters
Europe’s venture market has been recovering from a post-2021 slump, and Q2’s strong data suggests a durable upswing rather than a one-off spike. The concentration of capital in AI and deep tech signals that Europe is building competitive advantages in these fields, particularly in the U.K., which now leads the region by a wide margin. For startups outside the top markets, the picture is more challenging: deal counts declined at the seed stage, and early-stage rounds dipped year over year. The funding environment remains bifurcated, with large companies in hot sectors commanding outsized sums while smaller firms face a tighter fundraising climate. Overall, the quarter shows that European venture capital is regaining momentum, but the recovery is uneven and heavily tilted toward scale.
Looking ahead, M&A activity in Europe held steady in Q2, providing another exit path for investors even as public-market listings remain subdued. If mega-rounds continue and the U.K. maintains its pace, Europe could approach its 2021 funding levels by year-end — though the gap with North America’s record-setting market remains enormous.



